ASTH Overview

Astrana Health, Inc. is a physician-centric, artificial intelligence (AI)-powered healthcare company focused on delivering patient-centered care. The Company provides care coordination services to each major constituent of the healthcare delivery system, including patients, families, primary care physicians, specialists, acute care hospitals, alternative sites of inpatient care, physician groups, and health plans. The Company's segments include Care Partners, Care Delivery, and Care Enablement. Its Care Partners segment is focused on building and managing provider networks by partnering with, empowering, and investing in provider partners aligned on a shared vision for coordinated care delivery. Its Care Delivery organization includes primary care, multi-specialty care, and ancillary care services. Its Care Enablement segment represents a comprehensive platform that integrates clinical, operational, financial, and administrative information. It supports more than 20,000 providers.

Wall Street analysts forecast ASTH stock price to rise over the next 12 months. According to Wall Street analysts, the average 1-year price target for ASTH is33.20 USD with a low forecast of 26.00 USD and a high forecast of 40.00 USD. However, analyst price targets are subjective and often lag stock prices, so investors should focus on the objective reasons behind analyst rating changes, which better reflect the company's fundamentals.

Astrana Health Inc revenue for the last quarter amounts to 965.10M USD, increased 55.56

Astrana Health Inc. EPS for the last quarter amounts to 0.29 USD, increased 107.14

Astrana Health Inc (ASTH) has 3000 emplpoyees as of May 17 2026.

Today ASTH has the market capitalization of 2.13B USD.